Statins could reduce cholesterol synthesis via inhibiting HMG-CoA reductase and therefore are commonly used in hyperlipidemia patients for reducing levels of TC and LDL; of note that its efficacy and dose are positively associated. The gene discussed is HMGCR; the disease is hyperlipidemia.